Detalhe da pesquisa
1.
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.
Ann Oncol
; 33(5): 466-487, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35176458
2.
Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer.
Cancer Immunol Immunother
; 70(3): 589-595, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-32915318
3.
Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts.
Ann Oncol
; 31(7): 873-883, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32240795
4.
Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial.
Ann Oncol
; 30(7): 1114-1120, 2019 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31020334
5.
Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms.
Ann Oncol
; 29(2): 301-310, 2018 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29309540
6.
Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancer.
Ann Oncol
; 29(9): 1964-1971, 2018 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30010763
7.
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.
Ann Oncol
; 29(1): 200-208, 2018 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29186353
8.
Reframing recalcitrance for small-cell lung cancer.
Ann Oncol
; 32(7): 829-830, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33957222
9.
Crizotinib: from discovery to accelerated development to front-line treatment.
Ann Oncol
; 27 Suppl 3: iii35-iii41, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27573754
10.
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
Ann Oncol
; 27(6): 1155-1160, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27013395
11.
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer.
Ann Oncol
; 26(3): 497-504, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25395283
12.
Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.
Br J Cancer
; 111(2): 413-20, 2014 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24983368
13.
Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients.
Br J Cancer
; 108(8): 1704-11, 2013 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-23519056
14.
Crizotinib: from discovery to accelerated development to front-line treatment.
Ann Oncol
; 29(4): 1073, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28398575
15.
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.
Br J Cancer
; 106(3): 508-16, 2012 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-22187035
16.
Antibiotic use reduces efficacy of tyrosine kinase inhibitors in patients with advanced melanoma and non-small-cell lung cancer.
ESMO Open
; 7(3): 100430, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35489288
17.
A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients - the ELDERS study.
ESMO Open
; 6(1): 100042, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33516147
18.
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer.
Clin Transl Radiat Oncol
; 28: 24-31, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33748440
19.
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials Unit.
Ann Oncol
; 21(2): 232-237, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19675093
20.
The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials.
Ann Oncol
; 21(10): 2023-2028, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20332134